Study uncovers hidden risks in normal kidney function tests

Researchers at Karolinska Institutet have found that even kidney test results within the normal range can signal future chronic kidney disease if they are low for a person's age. The study, based on data from over 1.1 million adults in Stockholm, introduces reference charts and an online tool to help doctors identify at-risk patients earlier. This could prevent serious damage, as kidney disease often goes undetected until half of kidney function is lost.

Chronic kidney disease affects 10 to 15 percent of adults worldwide and is projected to become one of the top five causes of years of life lost by 2040. A major issue is late diagnosis, with many patients only identified after more than half their kidney function has declined, limiting treatment options. To address this, scientists from Karolinska Institutet analyzed nearly seven million estimated glomerular filtration rate (eGFR) tests from 2006 to 2021, covering about 80 percent of Stockholm residents aged 40 to 100.

The team created population-based reference charts for eGFR, comparing an individual's results to age- and sex-matched norms rather than fixed cutoffs. This method, inspired by pediatric growth charts, aims to spot subtle risks sooner. "We were inspired by the growth and weight charts used in pediatrics, which intuitively help clinicians identify children at risk of obesity or undergrowth," said Yuanhang Yang, the study's first author and a postdoctoral researcher at Karolinska Institutet.

Key findings link lower eGFR percentiles to worse outcomes. People below the 25th percentile faced higher risks of kidney failure needing dialysis or transplantation. A U-shaped pattern emerged for mortality, with both very low and very high percentiles associated with increased death risk. Yet, clinical practice lags: only one in four individuals with eGFR above 60 ml/min/1.73 m² but below the 25th percentile received urinary albumin testing, crucial for early detection.

For instance, a 55-year-old woman with an eGFR of 80 might seem fine, but it places her in the 10th percentile for her age, tripling her future dialysis risk. "This signals an opportunity to act earlier," noted Juan Jesús Carrero, a professor at the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet.

The researchers developed a free online calculator by PhD student Antoine Creon to integrate these charts into routine care. Funded by entities like the Swedish Research Council and part of the SCREAM project, the study reports no conflicts of interest. Published in Kidney International, it underscores the need for age-adjusted evaluations to enable prevention.

Relaterte artikler

Global map and diverse people illustrating the rising prevalence of chronic kidney disease worldwide, with medical elements highlighting the need for early detection.
Bilde generert av AI

Chronic kidney disease now affects 788 million people worldwide, study finds

Rapportert av AI Bilde generert av AI Faktasjekket

A Lancet analysis estimates that nearly 800 million adults were living with chronic kidney disease in 2023—up from 378 million in 1990—with the illness now ranking ninth among global causes of death. Researchers urge earlier detection and wider access to proven treatments.

A large study published in Neurology finds that impaired kidney function is linked to higher levels of Alzheimer’s biomarkers in the blood, without increasing overall dementia risk. However, among people who already have elevated biomarker levels, poor kidney health may hasten when dementia symptoms appear, underscoring the need to factor kidney function into interpretation of Alzheimer’s blood tests.

Rapportert av AI

Katie Wells, founder of Wellness Mama, shares insights from her personalized health risk assessment using AI-driven tools, highlighting how lifestyle factors can significantly influence chronic disease risks. The assessment, powered by data from over 10,000 studies, showed her cancer risk below the population average despite family history. It underscores a shift toward proactive prevention over reactive medicine.

Cases of colorectal cancer in people under 50 are increasing in many countries, alarming health experts. A recent international study found rising incidence in 27 of 50 countries through 2017, while researchers point to lifestyle factors, obesity and inherited genetic risks, and highlight new non‑invasive tests that could help close screening gaps.

Rapportert av AI Faktasjekket

A large Mayo Clinic study reports that current guidelines fail to detect nearly 90% of people with familial hypercholesterolemia, a common inherited cause of dangerously high cholesterol and early heart disease. Researchers analyzed exome data from more than 84,000 participants and found that most would not have been selected for standard genetic testing. Expanding routine DNA screening, they say, could help identify at-risk individuals earlier and prevent severe cardiovascular outcomes.

Americans born in the 1960s and early 1970s face higher loneliness, depression, and physical declines than previous generations, a trend not seen in other wealthy countries. A new study highlights how weaker family policies, healthcare access, and rising inequality contribute to this U.S.-specific crisis. In Nordic Europe, midlife well-being has improved instead.

Rapportert av AI

Prof KVS Hari, director of the Centre for Brain Research at IISc Bengaluru, emphasized digital biomarkers for early detection and prevention of dementia. He noted that India's rapidly aging population makes dementia a major public health challenge. The centre focuses on data collection and AI to understand disease progression in the Indian context.

 

 

 

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis